Publications
Product
Comparison of CYP3A4 and CYP3A5: the effects of cytochrome b5 and NADPH-cytochrome P450 reductase on testosterone hydroxylation activities. (BMRC)
Drug Metab Pharmacokinet. 27(6):663-7 / 2012.12 [LINK]
2012-International
Effects of testosterone and 17β-oestradiol on expression of the G protein-coupled receptor P2Y12 in megakaryocytic DAMI cells. (BMRC, PRCDM)
Platelets. 23(8):579-85 / 2012.12 [LINK]
2012-International
Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5. (BMRC)
Xenobiotica. 42(3):278-84 / 2012.03 [LINK]
2012-International
Identification of P2Y12 single-nucleotide polymorphisms and their influences on the variation in ADP-induced platelet aggregation. (BMRC, PRCDM)
Thromb Res. 127(3):220-7 / 2011.03 [LINK]
2011-International
Genetic variations in UDP-glucurosyltransferase 2B7 gene (UGT2B7) in a Korean population (BMRC, PRCDM)
Drug Metab Pharmacokinet. 25(4):398-402 / 2010.09 [LINK]
2010-International
A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients (BMRC, PRCDM)
Br J Clin Pharmacol. 70(2):213-21. / 2010.08 [LINK]
2010-International
Identification of CYP19A1 single nucleotide polymorphisms and their haplotype distributions in a Korean population (BMRC, PRCDM)
J Hum Genet. 55(3):189-93 / 2010.03 [LINK]
Identification of new CYP2C19 variants exhibiting decreased enzyme activity in the metabolism of S-mephenytoin and omeprazole (BMRC, PRCDM)
Drug Metab Dispos. / 37(11):2262-9 [LINK]
2009-International
Ethnic Differences of two Non-synonymous Single Nucleotide Polymorphisms in CDA Gene (BMRC, Japan Fund)
Drug Metab. Pharmacokinet. / 24(6):553?556 [LINK]
2009-International
Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans (BMRC, PRCDM)
Drug Metab Dispos. 37(7):1464-70, 2009 Jul [LINK ]
2009-International 
